CAS: 544417-40-5
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | CAPADENOSON REF: AN-AG00DB5CCAS: 544417-40-5 | 98+% | 76.00 €~547.00 € | Thu 09 May 24 |
 | Capadenoson REF: TM-TQ0125CAS: 544417-40-5 | 99.62% | 64.00 €~308.00 € | Thu 16 May 24 |
 | Capadenoson REF: 3D-BC176871CAS: 544417-40-5 | Min. 95% | 227.00 €~740.00 € | Tue 21 May 24 |
CAPADENOSON
CAS:544417-40-5
Formula:
C25H18ClN5O2S2
Purity:
98+%
Color and Shape:
Solid
Molecular weight:
520.0257
Ref: AN-AG00DB5C
| 10mg | 93.00 € | |
| 25mg | 172.00 € | |
| 50mg | 220.00 € | |
| 100mg | 547.00 € |
Estimated delivery in United States, on Thursday 9 May 2024
Capadenoson
CAS:544417-40-5
Capadenoson (BAY 68-4986) is a selective adenosine-A1 receptor agonist.
Formula:
C25H18ClN5O2S2
Purity:
99.62%
Color and Shape:
Solid
Molecular weight:
520.03
Ref: TM-TQ0125
| 5mg | 64.00 € | |
| 10mg | 94.00 € | |
| 25mg | 183.00 € | |
| 50mg | 308.00 € | |
| 1ml*10 (DMSO) | 73.00 € |
Estimated delivery in United States, on Thursday 16 May 2024
Ref: 3D-BC176871
| 5mg | 227.00 € | |
| 10mg | 307.00 € | |
| 25mg | 522.00 € | |
| 50mg | 619.00 € | |
| 100mg | 740.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024
